Harm reduction: Moving through the third decade

International Journal of Drug Policy

Volumn 21, Issue 2, 2010, Pages 91-93

  Stimson, Gerry V ^a   O'Hare, Pat ^a,b  

^a HARM REDUCTION INTERNATIONAL   (United Kingdom)

^b HIT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUPRENORPHINE; DIAMORPHINE; METHADONE; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; DRUG CONTROL; DRUNKEN DRIVING; EDITORIAL; HARM REDUCTION; HEALTH CARE POLICY; HEALTH PROGRAM; HEPATITIS B; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; OPIATE ADDICTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK REDUCTION; SMOKING; SUBSTITUTION THERAPY;

HARM REDUCTION; HEALTH POLICY; HIV INFECTIONS; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 77949318043     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.02.002     Document Type: Editorial

References (33)

1. Advisory Council on the Misuse of Drugs. Report. AIDS and drug misuse. Part 1 (1988), Her Majesty's Stationary Office, London
2. Albert E.R., and Byrne J. Coexisting or conjoined: The growth of the International drug users' movement through participation with IHRA conferences. International Journal of Drug Policy 21 2 (2010) 110-111
3. Ashton J.R., and Seymour H. Public health and the origins of the Mersey Model of harm reduction. International Journal of Drug Policy 21 2 (2010) 94-96
4. Atun R., and Kazatchkine M. The global fund's leadership on harm reduction: 2002-09. International Journal of Drug Policy 21 2 (2010) 103-106
5. Ball, A., Beg, M., Doupe, A., & Weiler, G. (Eds.) (2005). World Health Organization-Evidence for Action for HIV Prevention, Treatment and Care among Injecting Drug Users. International Journal of Drug Policy, 16(Suppl. 1).
6. Barrett D. Security, development and human rights: Normative, legal and policy challenges for the international drug control system. International Journal of Drug Policy 21 2 (2010) 140-144
7. Bergenstrom A., McLeod R.S., Sharma M., Mesquita F., Dorabjee J., Atun R., et al. How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia. International Journal of Drug Policy 21 2 (2010) 107-109
8. Bridge J. Route transition interventions: Potential public health gains from reducing or preventing injecting. International Journal of Drug Policy 21 2 (2010) 125-128
9. Bruce R.D. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy 21 2 (2010) 122-124
10. Chatterjee A., and Sharma M. Moving from a project to programmatic response: Scaling up harm reduction in Asia. International Journal of Drug Policy 21 2 (2010) 134-136
11. Cook, C., Bridge, J., & Stimson, G. V. (2010). The diffusion of harm reduction in Europe and beyond. In T. Rhodes (Ed.), Harm reduction: Evidence, impacts and challenges, Scientific Monograph Series No 10. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction. Office for Official Publications of the European Communities.
12. Cook C., and Kanaef N. Global state of harm reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics (2008), International Harm Reduction Association, London
13. Des Jarlais D.C. Learning from HIV epidemics among injecting drug users. International Journal of Drug Policy 21 2 (2010) 97-99
14. Erickson P., and Hathaway A.D. Normalization and harm reduction: Research avenues and policy agendas. International Journal of Drug Policy 21 2 (2010) 137-139
15. Gartner C., and Hall W. Harm reduction policies for tobacco users. International Journal of Drug Policy 21 2 (2010) 129-130
16. Haemmig, R. (2009). Personal communication.
17. International Harm Reduction Association. What is harm reduction? A position statement from the International Harm Reduction Association (2009), International Harm Reduction Association, London
18. International Harm Reduction Association and Human Rights Watch. Building consensus: A reference guide to human rights and drug policy (2009), International Harm Reduction Association, London
19. Institute of Medicine. Preventing HIV infection among injecting drug users in high risk countries: An assessment of the evidence (2006), The National Academies Press, Washington, DC
20. Islam M.M., Day C.A., and Conigrave K.M. Harm reduction healthcare: From an alternative to the mainstream platform?. International Journal of Drug Policy 21 2 (2010) 131-133
21. Kamarulzaman A., and Saifuddeen S.M. Islam and harm reduction. International Journal of Drug Policy 21 2 (2010) 115-118
22. Maguet O., and Majeed M. A challenge for the future: Introducing and scaling up harm reduction in Afghanistan, the worldwide opium supplier. International Journal of Drug Policy 21 2 (2010) 119-121
23. Mathers M., Cook C., and Degenhardt L. Improving the data to improve the global response to HIV among people who inject drugs. International Journal of Drug Policy 21 2 (2010) 100-102
24. Merkinaite S., Grund J.P., and Frimpong A. Young people and drugs: Next generation of harm reduction. International Journal of Drug Policy 21 2 (2010) 112-114
25. Michels I., and Stover H. Harm reduction-From a conceptual framework to practical experience: The example of Germany. Substance use und misuse special edition on interventions, policies and evidence: Taking an experimental look at international drug control (2009)
26. Newcombe R. High time for harm reduction. Druglink 2 1 (1987) 10-11
27. Rhodes, T., Hartnoll, R., & Johnson, A. (1991). Out of the agency and on to the streets: A review of HIV outreach health education in Europe and the United States. London: Institute for the Study of Drug Dependence, Research Monograph 2.
28. UNAIDS. Intensifying HIV prevention: UNAIDS policy position paper (2005). http://data.unaids.org/publications/irc-pub06/jc1165-intensif_hiv-newsty le_en.pdf http://data.unaids.org/publications/irc-pub06/jc1165-intensif_hiv-newsty le_en.pdf
29. United Nations General Assembly (2006). Resolution 60/262, Political declaration on HIV/AIDS, A/RES/60/262. Available online at: http://www.un.org/ga/president/62/issues/hiv/N0550332.pdf.
30. UNAIDS. Financial resources required to achieve universal access to HIV prevention, treatment, care and support (2007). http://data.unaids.org/pub/Report/2007/JC1678_Fin_Res_Req_en.pdf Available online at: http://data.unaids.org/pub/Report/2007/JC1678_Fin_Res_Req_en.pdf
31. United Nations Human Rights Council (2009). Resolution 12/27, The protection of human rights in the context of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). UN Doc No A/HRC/RES/12/27, October 22, 2009.
32. Wodak, A. (2009). Personal communication.
33. World Health Organization. WHO, UNAIDS and UNODC: Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users (2009), WHO, Geneva